IE
IDXX icon

Israel Englander’s Idexx Laboratories IDXX Stock Holding History

Israel Englander’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.53M Sell
18,100
-15,400
-46% -$8.64M ﹤0.01% 2322
2026
Q1 		$18.8M Sell
33,500
-7,800
-19% -$5M 0.01% 1605
2025
Q4 		$27.9M Buy
41,300
+13,000
+46% +$8.85M 0.01% 1247
2025
Q3 		$18.1M Sell
28,300
-10,900
-28% -$6.62M 0.01% 1776
2025
Q2 		$21M Buy
39,200
+9,800
+33% +$4.69M 0.01% 1527
2025
Q1 		$12.3M Buy
29,400
+27,700
+1,629% +$12M 0.01% 1968
2024
Q4 		$703K Sell
1,700
-13,300
-89% -$5.83M ﹤0.01% 4476
2024
Q3 		$7.58M Sell
15,000
-19,200
-56% -$9.33M ﹤0.01% 2453
2024
Q2 		$16.7M Buy
34,200
+25,200
+280% +$12.7M 0.01% 1655
2024
Q1 		$4.86M Sell
9,000
-14,900
-62% -$8.14M ﹤0.01% 2893
2023
Q4 		$13.3M Buy
23,900
+6,900
+41% +$3.24M 0.01% 1927
2023
Q3 		$7.43M Buy
17,000
+14,900
+710% +$7.43M ﹤0.01% 2340
2023
Q2 		$1.05M Buy
2,100
+1,300
+163% +$623K ﹤0.01% 4003
2023
Q1 		$400K Sell
800
-4,500
-85% -$2.15M ﹤0.01% 4733
2022
Q4 		$2.16M Sell
5,300
-3,700
-41% -$1.44M ﹤0.01% 3499
2022
Q3 		$2.93M Hold
9,000
– – ﹤0.01% 3415
2022
Q2 		$3.16M Buy
+9,000
New +$3.67M ﹤0.01% 3243
2022
Q1 		– Sell
-4,000
Closed -$2.63M – 7150
2021
Q4 		$2.63M Sell
4,000
-1,700
-30% -$1.07M ﹤0.01% 3519
2021
Q3 		$3.54M Buy
5,700
+500
+10% +$336K ﹤0.01% 3279
2021
Q2 		$3.28M Sell
5,200
-1,300
-20% -$718K ﹤0.01% 3327
2021
Q1 		$3.18M Buy
6,500
+1,500
+30% +$752K ﹤0.01% 3074
2020
Q4 		$2.5M Sell
5,000
-8,000
-62% -$3.58M ﹤0.01% 3058
2020
Q3 		$5.11K Buy
13,000
+3,000
+30% +$1.11M 0.01% 1822
2020
Q2 		$3.3M Buy
+10,000
New +$2.9M ﹤0.01% 2135
2020
Q1 		– Sell
-15,000
Closed -$3.92M – 4146
2019
Q4 		$3.92M Buy
15,000
+13,000
+650% +$3.43M ﹤0.01% 2127
2019
Q3 		$543K Buy
+2,000
New +$557K ﹤0.01% 3204
2019
Q2 		– Sell
-10,000
Closed -$2.24M – 4219
2019
Q1 		$2.24M Buy
+10,000
New +$2.06M ﹤0.01% 2333

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Israel Englander's IDXX Position: Q2 2026 in Review

Israel Englander increased its Idexx Laboratories (IDXX) stake by 12% in Q2 2026, buying an estimated $4.79M and bringing the position to 78,980 shares worth $41.6M. The position accounts for 0.02% of the portfolio, ranked #1019.

Israel Englander first reported a position in IDXX in Q4 2013 and has held it in 46 quarters since. The position peaked at $181M in Q4 2023. 1,293 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Israel Englander held 78,980 shares of Idexx Laboratories worth $41.6M as of Q2 2026.
  • Israel Englander bought 8,534 Idexx Laboratories shares in Q2 2026, an estimated $4.79M.
  • Idexx Laboratories made up 0.02% of Israel Englander's portfolio in Q2 2026, its #1019 holding.
  • Israel Englander first reported a position in Idexx Laboratories in Q4 2013 and has held it in 46 quarters since.
  • Israel Englander's Idexx Laboratories position peaked at $181M in Q4 2023.
  • 1,293 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.